Megan Cully
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer
- Metabolism, Diabetes, and Cancer
- Extracellular vesicles in disease
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 7
- Ubiquitin and proteasome pathways 6
- RNA modifications and cancer 6
- RNA Research and Splicing 5
- Oncology 23
- CAR-T cell therapy research 8
- Cancer-related Molecular Pathways 5
- Co-authors
- Tak W. Mak (3 shared papers)Arnold J. Levine (1 shared paper)Han You (1 shared paper)Sally J. Leevers (4 shared papers)Mary Wu (2 shared papers)John R. Griffiths (1 shared paper)Yuen‐Li Chung (1 shared paper)Cláudio R. Santos (1 shared paper)
- Journals
- Nature Reviews Drug Discovery (86 papers)Nature Reviews Cardiology (13 papers)Nature Reviews Rheumatology (6 papers)Nature reviews. Cancer (3 papers)Nature (3 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Megan Cully
121 papers receiving 3.4k citations
Megan Cully's Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 699
- Molecular Biology 2.0k
- Aging 49
- Biochemistry 150
- Immunology 369
Countries citing papers authored by Megan Cully
This map shows the geographic impact of Megan Cully's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Cully with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Cully more than expected).
Fields of papers citing papers by Megan Cully
This network shows the impact of papers produced by Megan Cully. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Cully. The network helps show where Megan Cully may publish in the future.
Co-authors
The 25 scholars most cited alongside Megan Cully, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth Hit paper breakdown → | 2008 | 1119 |
| 2 | Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis Hit paper breakdown → | 2006 | 987 |
| 3 | 2020 | 169 | |
| 4 | 2014 | 109 | |
| 5 | 2021 | 94 | |
| 6 | 2009 | 73 | |
| 7 | 2019 | 65 | |
| 8 | 2019 | 59 | |
| 9 | 2008 | 58 | |
| 10 | 2019 | 43 | |
| 11 | 2005 | 42 | |
| 12 | 2018 | 38 | |
| 13 | 2006 | 35 | |
| 14 | 2016 | 32 | |
| 15 | 2009 | 30 | |
| 16 | 2017 | 25 | |
| 17 | 2015 | 22 | |
| 18 | 2004 | 16 | |
| 19 | 2018 | 15 | |
| 20 | 2020 | 13 |
About Megan Cully
Megan Cully is a scholar working on Molecular Biology, Oncology, Immunology, Surgery and Cardiology and Cardiovascular Medicine, having authored 129 papers that have together received 3.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Immune Cell Function and Interaction (7 papers), Ubiquitin and proteasome pathways (6 papers), RNA modifications and cancer (6 papers), Atrial Fibrillation Management and Outcomes (6 papers), RNA Research and Splicing (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (699 citations), Molecular Biology (2.0k citations), Aging (49 citations), Biochemistry (150 citations) and Immunology (369 citations). Megan Cully has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Tak W. Mak, Arnold J. Levine, Han You, Sally J. Leevers, Mary Wu, John R. Griffiths, Yuen‐Li Chung, Cláudio R. Santos, Thomas Porstmann and B Griffiths. Their work appears in journals such as Nature Reviews Drug Discovery, Nature Reviews Cardiology, Nature Reviews Rheumatology, Nature reviews. Cancer and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.